107
Views
15
CrossRef citations to date
0
Altmetric
Drug Profile

Role of carvedilol controlled-release in cardiovascular disease

Pages 483-498 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohammad Amin Rezvanfar, Sarah Saeedi, Parisa Mansoori, Sepideh Saadat, Maziar Goosheh, Habib A. Shojaei Saadi, Maryam Baeeri & Mohammad Abdollahi. (2016) Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary. Pharmaceutical Biology 54:1, pages 80-90.
Read now

Articles from other publishers (14)

Hemat H. Attia, Dalia S. Shaker, Aliaa ElMeshad & Maha El-Kayal. (2023) Optimization and in-vitro assessment of the effectiveness of carvedilol-loaded proniosomal gels as a promising therapeutic approach for the topical treatment of skin cancer. Journal of Drug Delivery Science and Technology 86, pages 104665.
Crossref
Olabode Oluwadare Akintoye, Ayodeji Johnson Ajibare, Isaac Adeola Oriyomi, Babatunde Ajayi Olofinbiyi, Grace Oyiza Yusuf, Damilola Christanah Afuye, Temitope Kabirat Babalola, Oluwadamilola Esther Faturoti, Seun Oludipe & Victor Bamidele Owoyele. (2023) Synergistic action of carvedilol and clomiphene in mitigating the behavioral phenotypes of letrozole-model of PCOS rats by modulating the NRF2/NFKB pathway. Life Sciences 324, pages 121737.
Crossref
Fedora Grande, Giuseppina Ioele, Anna Caruso, Maria Antonietta Occhiuzzi, Hussein El-Kashef, Carmela Saturnino & Maria Stefania Sinicropi. (2022) Carbazoles: Role and Functions in Fighting Diabetes. Applied Sciences 13:1, pages 349.
Crossref
Marzieh Farahani-Zangaraki, Azade Taheri & Mahmoud Etebari. (2021) Niosome-carvedilol protects DNA damage of supraphysiologic concentrations of insulin using comet assay: An in vitro study. Human & Experimental Toxicology 40:12_suppl, pages S150-S157.
Crossref
Qi Zhang, Baolin Huang, Hongjiao Xue, Zimin Lin, Jie Zhao & Zheng Cai. (2021) Preparation, Characterization, and Selection of Optimal Forms of (S)-Carvedilol Salts for the Development of Extended-Release Formulation. Molecular Pharmaceutics 18:6, pages 2298-2310.
Crossref
Gilda Varricchi, Pietro Ameri, Christian Cadeddu, Alessandra Ghigo, Rosalinda Madonna, Giancarlo Marone, Valentina Mercurio, Ines Monte, Giuseppina Novo, Paolo Parrella, Flora Pirozzi, Antonio Pecoraro, Paolo Spallarossa, Concetta Zito, Giuseppe Mercuro, Pasquale Pagliaro & Carlo G. Tocchetti. (2018) Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. Frontiers in Physiology 9.
Crossref
Hiren Prajapati, Ramandeep Sharma & Dixit Patel. (2016) Carvedilol: a review of its use in the management of heart failure. Drugs & Therapy Perspectives 33:3, pages 147-152.
Crossref
Alessia Arcaro, Flora Pirozzi, Annalisa Angelini, Cristina Chimenti, Lia Crotti, Carla Giordano, Daniele Mancardi, Daniele Torella & Carlo G. Tocchetti. (2016) Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology. Oxidative Medicine and Cellular Longevity 2016, pages 1-13.
Crossref
Marilisa Molinaro, Pietro Ameri, Giancarlo Marone, Mario Petretta, Pasquale Abete, Fabio Di Lisa, Sabino De Placido, Domenico Bonaduce & Carlo G. Tocchetti. (2015) Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. BioMed Research International 2015, pages 1-14.
Crossref
Alessia Arcaro, Giuseppe Lembo & Carlo G. Tocchetti. (2014) Nitroxyl (HNO) for Treatment of Acute Heart Failure. Current Heart Failure Reports 11:3, pages 227-235.
Crossref
Carol Chen-Scarabelli, Louis SaravolatzIIII, Yahya Murad, Wen-Shi Shieh, Waqas Qureshi, Justin Di Rezze, Rodeo Abrencillo, Tova Gardin, Umesh K. Gidwani, Louis Saravolatz, Giuseppe Faggian & Tiziano M. Scarabelli. (2012) A Critical Review of the Use of Carvedilol in Ischemic Heart Disease. American Journal Cardiovascular Drugs 12:6, pages 391-401.
Crossref
Carol Chen-Scarabelli, Louis SaravolatzIIII, Yahya Murad, Wen-Shi Shieh, Waqas Qureshi, Justin Di Rezze, Rodeo Abrencillo, Tova Gardin, Umesh K. Gidwani, Louis Saravolatz, Giuseppe Faggian & Tiziano M. Scarabelli. (2012) A Critical Review of the Use of Carvedilol in Ischemic Heart Disease. American Journal of Cardiovascular Drugs 12:6, pages 391-401.
Crossref
Carlo G. TocchettiBrian A. StanleyChristopher I. MurrayVidhya SivakumaranSonia DonzelliDaniele MancardiPasquale PagliaroWei Dong GaoJennifer van EykDavid A. KassDavid A. WinkNazareno Paolocci. (2011) Playing with Cardiac “Redox Switches”: The “HNO Way” to Modulate Cardiac Function. Antioxidants & Redox Signaling 14:9, pages 1687-1698.
Crossref
Marco Metra & Michael R. Bristow. 2011. Heart Failure: A Companion to Braunwald's Heart Disease. Heart Failure: A Companion to Braunwald's Heart Disease 674 693 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.